Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Cefalexin; Dihydrostreptomycin
Bimeda Chemicals
QJ51RD01
Cefalexin; Dihydrostreptomycin
500/500 mg/syringe
Intramammary suspension
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle
cefalexin, combinations with other antibacterials
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT KEFAMAST Dry Cow Intramammary Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Intramammary suspension. 10 ml intramammary syringe containing 9 g of a smooth pale pink or pale yellow sterile product. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dry Cows. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of sub clinical mastitis infection present at drying off and to assist in preventing new infections occurring during the dry period. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active ingredients. Do not use in lactating cows. Do not use within 40 days of the estimated calving date. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. Each syringe contains: ACTIVE SUBSTANCES Cefalexin 500 mg Dihydrostreptomycin (as Dihydrostreptomycin Sulphate) 500 mg H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _8_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _3_ _7_ _5_ _2_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS Not intended for use within 40 days of the estimated calving date. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Operators should avoid contact with this preparation as occasional skin allergy may occur. Penicillins and c Lestu allt skjalið